Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 373 articles:
HTML format
Text format



Single Articles


    January 2017
  1. CHANNANATH AM, Elkum N, Al-Abdulrazzaq D, Tuomilehto J, et al
    Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.
    PLoS One. 2017;12:e0175728.
    PubMed     Text format     Abstract available


  2. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Text format     Abstract available


  3. DE MACEDO MSFC, Costa KM, da Silva Filho M
    Voice disorder in systemic lupus erythematosus.
    PLoS One. 2017;12:e0175893.
    PubMed     Text format     Abstract available


  4. ZHANG JJ, Yu GZ, Zheng ZH, Liu YF, et al
    Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    PLoS One. 2017;12:e0175828.
    PubMed     Text format     Abstract available


  5. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Text format     Abstract available


  6. HO TW, Huang CT, Ruan SY, Tsai YJ, et al
    Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
    PLoS One. 2017;12:e0175794.
    PubMed     Text format     Abstract available


  7. LI JN, Jia X, Wang Y, Xie C, et al
    Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides.
    PLoS One. 2017;12:e0174553.
    PubMed     Text format     Abstract available


  8. HINTSA S, Dube L, Abay M, Angesom T, et al
    Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study.
    PLoS One. 2017;12:e0173566.
    PubMed     Text format     Abstract available


  9. KRAMER J, Tenberge JG, Kleiter I, Gaissmaier W, et al
    Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    PLoS One. 2017;12:e0174858.
    PubMed     Text format     Abstract available


  10. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Text format     Abstract available


  11. GUSTAFSSON JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, et al
    Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    PLoS One. 2017;12:e0174572.
    PubMed     Text format     Abstract available


  12. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Text format     Abstract available


    January 2016
  13. WANG H, Sha LL, Ma TT, Zhang LX, et al
    Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    PLoS One. 2016;11:e0148197.
    PubMed     Text format     Abstract available


  14. RASCHE L, Heiserich L, Behrens JR, Lenz K, et al
    Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
    PLoS One. 2016;11:e0147968.
    PubMed     Text format     Abstract available


  15. NASH EE, Peters BM, Lilly EA, Noverr MC, et al
    A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.
    PLoS One. 2016;11:e0147969.
    PubMed     Text format     Abstract available


  16. CHENG ST, Chen L, Li SY, Mayoux E, et al
    The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic beta-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
    PLoS One. 2016;11:e0147391.
    PubMed     Text format     Abstract available


  17. MAEDA Y, Migita K, Higuchi O, Mukaino A, et al
    Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
    PLoS One. 2016;11:e0146048.
    PubMed     Text format     Abstract available


  18. SHINTO L, Marracci G, Mohr DC, Bumgarner L, et al
    Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
    PLoS One. 2016;11:e0147195.
    PubMed     Text format     Abstract available


  19. NIELSEN CH, Bornsen L, Sellebjerg F, Brimnes MK, et al
    Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-alpha and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0146971.
    PubMed     Text format     Abstract available


  20. CHAYKOVSKA L, Heunisch F, von Einem G, Alter ML, et al
    Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography.
    PLoS One. 2016;11:e0145723.
    PubMed     Text format     Abstract available


  21. POPESCU V, Schoonheim MM, Versteeg A, Chaturvedi N, et al
    Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
    PLoS One. 2016;11:e0143942.
    PubMed     Text format     Abstract available


  22. LITTERA R, Chessa L, Onali S, Figorilli F, et al
    Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    PLoS One. 2016;11:e0146086.
    PubMed     Text format     Abstract available


  23. KREMER D, Cui QL, Gottle P, Kuhlmann T, et al
    CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
    PLoS One. 2016;11:e0146503.
    PubMed     Text format     Abstract available


  24. ZHOU F, Zhuang Y, Gong H, Zhan J, et al
    Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0146080.
    PubMed     Text format     Abstract available


  25. KIISKI HS, Ni Riada S, Lalor EC, Goncalves NR, et al
    Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
    PLoS One. 2016;11:e0146084.
    PubMed     Text format     Abstract available


  26. HENNERICI T, Pollmann R, Schmidt T, Seipelt M, et al
    Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.
    PLoS One. 2016;11:e0148919.
    PubMed     Text format     Abstract available


  27. TSCHOCHNER M, Leary S, Cooper D, Strautins K, et al
    Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    PLoS One. 2016;11:e0147567.
    PubMed     Text format     Abstract available


  28. BONNIER G, Kober T, Schluep M, Du Pasquier R, et al
    A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
    PLoS One. 2016;11:e0148631.
    PubMed     Text format     Abstract available


  29. LIAO Z, Tang H, Xu X, Liang Y, et al
    Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.
    PLoS One. 2016;11:e0147856.
    PubMed     Text format     Abstract available


  30. WIENDL H, Butzkueven H, Kappos L, Trojano M, et al
    Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
    PLoS One. 2016;11:e0144834.
    PubMed     Text format     Abstract available


  31. RODIC SZ, Knezevic TI, Kisic-Tepavcevic DB, Dackovic JR, et al
    Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
    PLoS One. 2016;11:e0147042.
    PubMed     Text format     Abstract available


  32. JALILI RB, Zhang Y, Hosseini-Tabatabaei A, Kilani RT, et al
    Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    PLoS One. 2016;11:e0146970.
    PubMed     Text format     Abstract available


  33. RAJAKULENDRAN S, Pitceathly RD, Taanman JW, Costello H, et al
    A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.
    PLoS One. 2016;11:e0145500.
    PubMed     Text format     Abstract available


  34. RASENACK M, Rychen J, Andelova M, Naegelin Y, et al
    Efficacy and Safety of Fingolimod in an Unselected Patient Population.
    PLoS One. 2016;11:e0146190.
    PubMed     Text format     Abstract available


  35. MURRAY SG, Schmajuk G, Trupin L, Gensler L, et al
    National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.
    PLoS One. 2016;11:e0144918.
    PubMed     Text format     Abstract available


  36. LIANG D, Zuo A, Zhao R, Shao H, et al
    CD73 Expressed on gammadelta T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis.
    PLoS One. 2016;11:e0150078.
    PubMed     Text format     Abstract available


  37. KLISTORNER A, Wang C, Yiannikas C, Graham SL, et al
    Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
    PLoS One. 2016;11:e0149245.
    PubMed     Text format     Abstract available


  38. LO GULLO A, Koster MJ, Crowson CS, Makol A, et al
    Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
    PLoS One. 2016;11:e0149579.
    PubMed     Text format     Abstract available


  39. ZAINI WH, Giuliani F, Beaulieu C, Kalra S, et al
    Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.
    PLoS One. 2016;11:e0149622.
    PubMed     Text format     Abstract available


  40. KIM NS, Mbongue JC, Nicholas DA, Esebanmen GE, et al
    Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-kappaB Pathway.
    PLoS One. 2016;11:e0147509.
    PubMed     Text format     Abstract available


  41. TU Y, Wang Y, Ding L, Zhang J, et al
    Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.
    PLoS One. 2016;11:e0148595.
    PubMed     Text format     Abstract available


  42. MOTTA C, Palermo E, Studer V, Germanotta M, et al
    Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
    PLoS One. 2016;11:e0148997.
    PubMed     Text format     Abstract available


  43. VAN LEEUWEN N, Lingsma HF, Vanrolleghem AM, Sturkenboom MC, et al
    Hospital Admissions, Transfers and Costs of Guillain-Barre Syndrome.
    PLoS One. 2016;11:e0143837.
    PubMed     Text format     Abstract available


  44. MARCK CH, Neate SL, Taylor KL, Weiland TJ, et al
    Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
    PLoS One. 2016;11:e0148573.
    PubMed     Text format     Abstract available


  45. XIA L, Xie H, Yu Y, Zhou H, et al
    The Effects of NF-kappaB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-beta2GPI in Mouse.
    PLoS One. 2016;11:e0147958.
    PubMed     Text format     Abstract available


  46. D'SOUZA CA, Zhao FL, Li X, Xu Y, et al
    OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
    PLoS One. 2016;11:e0148439.
    PubMed     Text format     Abstract available


  47. TAM CC, O'Brien SJ
    Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom.
    PLoS One. 2016;11:e0138526.
    PubMed     Text format     Abstract available


  48. LEE JY, Bae K, Park KA, Lyu IJ, et al
    Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease.
    PLoS One. 2016;11:e0148167.
    PubMed     Text format     Abstract available


  49. NARRES M, Claessen H, Droste S, Kvitkina T, et al
    The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.
    PLoS One. 2016;11:e0147329.
    PubMed     Text format     Abstract available


  50. EHRMANN D, Bergis-Jurgan N, Haak T, Kulzer B, et al
    Comparison of the Efficacy of a Diabetes Education Programme for Type 1 Diabetes (PRIMAS) in a Randomised Controlled Trial Setting and the Effectiveness in a Routine Care Setting: Results of a Comparative Effectiveness Study.
    PLoS One. 2016;11:e0147581.
    PubMed     Text format     Abstract available


  51. VAN DER TORREN CR, Verrijn Stuart AA, Lee D, Meerding J, et al
    Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes.
    PLoS One. 2016;11:e0146649.
    PubMed     Text format     Abstract available


  52. AKBAR N, Giorgio A, Till C, Sled JG, et al
    Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
    PLoS One. 2016;11:e0145906.
    PubMed     Text format     Abstract available


  53. BRANGER P, Parienti JJ, Sormani MP, Defer G, et al
    The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
    PLoS One. 2016;11:e0149685.
    PubMed     Text format     Abstract available


  54. KAMEI K, Harada R, Hamada R, Sakai T, et al
    Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy.
    PLoS One. 2016;11:e0150885.
    PubMed     Text format     Abstract available


  55. RINALDUZZI S, Serafini M, Capozza M, Accornero N, et al
    Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    PLoS One. 2016;11:e0151629.
    PubMed     Text format     Abstract available


  56. TOUPIN APRIL K, Stinson J, Boon H, Duffy CM, et al
    Development and Preliminary Face and Content Validation of the "Which Health Approaches and Treatments Are You Using?" (WHAT) Questionnaires Assessing Complementary and Alternative Medicine Use in Pediatric Rheumatology.
    PLoS One. 2016;11:e0149809.
    PubMed     Text format     Abstract available


  57. PATEL H, Mansuri MS, Singh M, Begum R, et al
    Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.
    PLoS One. 2016;11:e0149441.
    PubMed     Text format     Abstract available


  58. HELLWIG K, Chen LH, Stancyzk FZ, Langer-Gould AM, et al
    Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.
    PLoS One. 2016;11:e0149094.
    PubMed     Text format     Abstract available


  59. THORNLEY TB, Agarwal KA, Kyriazis P, Ma L, et al
    Contrasting Roles of Islet Resident Immunoregulatory Macrophages and Dendritic Cells in Experimental Autoimmune Type 1 Diabetes.
    PLoS One. 2016;11:e0150792.
    PubMed     Text format     Abstract available


  60. JURECKA-LUBIENIECKA B, Bednarczuk T, Ploski R, Krajewska J, et al
    Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.
    PLoS One. 2016;11:e0150307.
    PubMed     Text format     Abstract available


  61. KOTHUR K, Wienholt L, Tantsis EM, Earl J, et al
    B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
    PLoS One. 2016;11:e0149411.
    PubMed     Text format     Abstract available


  62. LIN D, Luo X, Meng L, Zhang G, et al
    Optical Intensities of Different Compartments of Subretinal Fluid in Acute Vogt-Koyanagi-Harada Disease.
    PLoS One. 2016;11:e0149376.
    PubMed     Text format     Abstract available


  63. AN H, Lim C, Guillemin GJ, Vollmer-Conna U, et al
    Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
    PLoS One. 2016;11:e0149200.
    PubMed     Text format     Abstract available


  64. LU MC, Chang SC, Huang KY, Koo M, et al
    Higher Risk of Thyroid Disorders in Young Patients with Type 1 Diabetes: A 12-Year Nationwide, Population-Based, Retrospective Cohort Study.
    PLoS One. 2016;11:e0152168.
    PubMed     Text format     Abstract available


  65. PINTER D, Beckmann C, Koini M, Pirker E, et al
    Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
    PLoS One. 2016;11:e0152158.
    PubMed     Text format     Abstract available


  66. HAREL A, Ceccarelli A, Farrell C, Fabian M, et al
    Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
    PLoS One. 2016;11:e0152180.
    PubMed     Text format     Abstract available


  67. OJI S, Nicolussi EM, Kaufmann N, Zeka B, et al
    Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
    PLoS One. 2016;11:e0151244.
    PubMed     Text format     Abstract available


  68. BAGLAENKO Y, Manion KP, Chang NH, Gracey E, et al
    IL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone Mice.
    PLoS One. 2016;11:e0150515.
    PubMed     Text format     Abstract available


  69. LOMBARDO M, Parravano M, Serrao S, Ziccardi L, et al
    Investigation of Adaptive Optics Imaging Biomarkers for Detecting Pathological Changes of the Cone Mosaic in Patients with Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0151380.
    PubMed     Text format     Abstract available


  70. PRECHL J, Papp K, Herincs Z, Peterfy H, et al
    Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium.
    PLoS One. 2016;11:e0150685.
    PubMed     Text format     Abstract available


  71. SCHMITT A, Reimer A, Hermanns N, Huber J, et al
    Assessing Diabetes Self-Management with the Diabetes Self-Management Questionnaire (DSMQ) Can Help Analyse Behavioural Problems Related to Reduced Glycaemic Control.
    PLoS One. 2016;11:e0150774.
    PubMed     Text format     Abstract available


  72. LAIMER M, Melmer A, Mader JK, Schutz-Fuhrmann I, et al
    Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0150604.
    PubMed     Text format     Abstract available


  73. ONDA Y, Nishimura R, Morimoto A, Sano H, et al
    Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study.
    PLoS One. 2016;11:e0150720.
    PubMed     Text format     Abstract available


  74. LEE JY, Paik JS, Yun M, Lee SB, et al
    The Effect of (-)-Epigallocatechin-3-Gallate on IL-1beta Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy.
    PLoS One. 2016;11:e0148645.
    PubMed     Text format     Abstract available


  75. SIMON A, Subra JF, Guilpain P, Jeannin P, et al
    Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
    PLoS One. 2016;11:e0147091.
    PubMed     Text format     Abstract available


  76. WU T, Xie C, Han J, Ye Y, et al
    Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.
    PLoS One. 2016;11:e0151491.
    PubMed     Text format     Abstract available


  77. FAIZY TD, Thaler C, Kumar D, Sedlacik J, et al
    Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
    PLoS One. 2016;11:e0151496.
    PubMed     Text format     Abstract available


  78. CHEVALIER J, Chamoux C, Hammes F, Chicoye A, et al
    Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
    PLoS One. 2016;11:e0150703.
    PubMed     Text format     Abstract available


  79. WU X, Shen D, Li T, Zhang B, et al
    Distinct Clinical Characteristics of Pediatric Guillain-Barre Syndrome: A Comparative Study between Children and Adults in Northeast China.
    PLoS One. 2016;11:e0151611.
    PubMed     Text format     Abstract available


  80. ZHUANG Y, Li Y, Li X, Xie Q, et al
    Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis through an ROS-Mediated p38/MAPK Pathway.
    PLoS One. 2016;11:e0149754.
    PubMed     Text format     Abstract available


  81. PUT K, Brisse E, Avau A, Imbrechts M, et al
    IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    PLoS One. 2016;11:e0150075.
    PubMed     Text format     Abstract available


  82. LIU B, Yue Y, Yang Y, Jin Y, et al
    Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
    PLoS One. 2016;11:e0147260.
    PubMed     Text format     Abstract available


  83. RIVERA-LOPEZ R, Jimenez-Jaimez J, Sabio JM, Zamora-Pasadas M, et al
    Relationship between QT Interval Length and Arterial Stiffness in Systemic Lupus Erythematosus (SLE): A Cross-Sectional Case-Control Study.
    PLoS One. 2016;11:e0152291.
    PubMed     Text format     Abstract available


  84. DISANTO G, Benkert P, Lorscheider J, Mueller S, et al
    The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
    PLoS One. 2016;11:e0152347.
    PubMed     Text format     Abstract available


  85. KIM JH, Furrow E, Ritt MG, Utz PJ, et al
    Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes.
    PLoS One. 2016;11:e0152397.
    PubMed     Text format     Abstract available


  86. SHARMA A, Liu X, Hadley D, Hagopian W, et al
    Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort.
    PLoS One. 2016;11:e0152476.
    PubMed     Text format     Abstract available


  87. AUDEMARD-VERGER A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, et al
    Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.
    PLoS One. 2016;11:e0151696.
    PubMed     Text format     Abstract available


  88. BARBERA BETANCOURT A, Emery JL, Recino A, Wong FS, et al
    Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
    PLoS One. 2016;11:e0146516.
    PubMed     Text format     Abstract available


  89. EL-BADAWY A, El-Badri N
    Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis.
    PLoS One. 2016;11:e0151938.
    PubMed     Text format     Abstract available


  90. DAI R, Lu R, Ahmed SA
    The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation.
    PLoS One. 2016;11:e0153509.
    PubMed     Text format     Abstract available


  91. ARELLANO B, Hussain R, Miller-Little WA, Herndon E, et al
    A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
    PLoS One. 2016;11:e0152720.
    PubMed     Text format     Abstract available


  92. JAIN S, Park G, Sproule TJ, Christianson GJ, et al
    Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice.
    PLoS One. 2016;11:e0153059.
    PubMed     Text format     Abstract available


  93. ZABEEN B, Craig ME, Virk SA, Pryke A, et al
    Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality.
    PLoS One. 2016;11:e0153033.
    PubMed     Text format     Abstract available


  94. NAGASAWA Y, Okuzaki D, Muso E, Yamamoto R, et al
    IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood.
    PLoS One. 2016;11:e0153252.
    PubMed     Text format     Abstract available


  95. RUGGAJO P, Svarstad E, Leh S, Marti HP, et al
    Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy-A Retrospective Registry-Based Cohort Study.
    PLoS One. 2016;11:e0153819.
    PubMed     Text format     Abstract available


  96. MASSOLT ET, Effraimidis G, Korevaar TI, Wiersinga WM, et al
    Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease.
    PLoS One. 2016;11:e0153892.
    PubMed     Text format     Abstract available


  97. ROSATO R, Testa S, Bertolotto A, Confalonieri P, et al
    Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
    PLoS One. 2016;11:e0153466.
    PubMed     Text format     Abstract available


  98. LIN CH, Hsieh SC, Keng LT, Lee HS, et al
    Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
    PLoS One. 2016;11:e0153938.
    PubMed     Text format     Abstract available


  99. VEDHARA K, Dawe K, Miles JN, Wetherell MA, et al
    Illness Beliefs Predict Mortality in Patients with Diabetic Foot Ulcers.
    PLoS One. 2016;11:e0153315.
    PubMed     Text format     Abstract available


  100. MURUNGA AN, Miruka DO, Driver C, Nkomo FS, et al
    Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model.
    PLoS One. 2016;11:e0153241.
    PubMed     Text format     Abstract available


  101. SUNDARRAJAN S, Arumugam M
    Comorbidities of Psoriasis - Exploring the Links by Network Approach.
    PLoS One. 2016;11:e0149175.
    PubMed     Text format     Abstract available


  102. KUSPINAR A, Pickard S, Mayo NE
    Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
    PLoS One. 2016;11:e0151905.
    PubMed     Text format     Abstract available


  103. OLSEN JA, Kenna LA, Spelios MG, Hessner MJ, et al
    Circulating Differentially Methylated Amylin DNA as a Biomarker of beta-Cell Loss in Type 1 Diabetes.
    PLoS One. 2016;11:e0152662.
    PubMed     Text format     Abstract available


  104. BARTH S, Haas JP, Schlichtiger J, Molz J, et al
    Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
    PLoS One. 2016;11:e0153267.
    PubMed     Text format     Abstract available


  105. MARANDA L, Gupta OT
    Association between Responsible Pet Ownership and Glycemic Control in Youths with Type 1 Diabetes.
    PLoS One. 2016;11:e0152332.
    PubMed     Text format     Abstract available


  106. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Text format     Abstract available


  107. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Text format     Abstract available


  108. MAGGI L, Margheri F, Luciani C, Capone M, et al
    Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.
    PLoS One. 2016;11:e0154422.
    PubMed     Text format     Abstract available


  109. RAMONDT S, Tiemensma J, Cameron LD, Broadbent E, et al
    Drawings of Blood Cells Reveal People's Perception of Their Blood Disorder: A Pilot Study.
    PLoS One. 2016;11:e0154348.
    PubMed     Text format     Abstract available


  110. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Text format     Abstract available


  111. HAASNOOT AJ, Vernie LA, Rothova A, V D Doe P, et al
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016;11:e0164312.
    PubMed     Text format     Abstract available


  112. KAUSHIK DK, Yong HY, Hahn JN, Silva C, et al
    Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
    PLoS One. 2016;11:e0163802.
    PubMed     Text format     Abstract available


  113. KALRON A, Givon U, Frid L, Dolev M, et al
    Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
    PLoS One. 2016;11:e0164467.
    PubMed     Text format     Abstract available


  114. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    PubMed     Text format     Abstract available


  115. RIEMANN-LORENZ K, Eilers M, von Geldern G, Schulz KH, et al
    Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.
    PLoS One. 2016;11:e0165246.
    PubMed     Text format     Abstract available


  116. MANICARDI V, Russo G, Napoli A, Torlone E, et al
    Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative.
    PLoS One. 2016;11:e0162960.
    PubMed     Text format     Abstract available


  117. JERNAS L, Wencel J, Wiak A, Bieniek M, et al
    Risk Factors for Poor Adherence to Betaferon(R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome.
    PLoS One. 2016;11:e0157950.
    PubMed     Text format     Abstract available


  118. OKANO J, Kojima H, Katagi M, Nakagawa T, et al
    Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.
    PLoS One. 2016;11:e0166215.
    PubMed     Text format     Abstract available


  119. DOBSON R, Ramagopalan S, Topping J, Smith P, et al
    A Risk Score for Predicting Multiple Sclerosis.
    PLoS One. 2016;11:e0164992.
    PubMed     Text format     Abstract available


  120. PROSPERINI L, de Rossi N, Scarpazza C, Moiola L, et al
    Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    PLoS One. 2016;11:e0168376.
    PubMed     Text format     Abstract available


  121. JOHNSON TW, Wu Y, Nathoo N, Rogers JA, et al
    Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0167196.
    PubMed     Text format     Abstract available


  122. VAN DALEM A, Demeester S, Balti EV, Keymeulen B, et al
    Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    PLoS One. 2016;11:e0166702.
    PubMed     Text format     Abstract available


  123. CHATTERJEE S, Bhardwaj N, Saxena RK
    Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.
    PLoS One. 2016;11:e0166878.
    PubMed     Text format     Abstract available


  124. MARTIN P, McGovern A, Massey J, Schoenfelder S, et al
    Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C.
    PLoS One. 2016;11:e0166923.
    PubMed     Text format     Abstract available


  125. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Text format     Abstract available


  126. RYDEN A, Sorstadius E, Bergenheim K, Romanovschi A, et al
    The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
    PLoS One. 2016;11:e0164977.
    PubMed     Text format     Abstract available


  127. KREMER IE, Evers SM, Jongen PJ, van der Weijden T, et al
    Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling.
    PLoS One. 2016;11:e0164862.
    PubMed     Text format     Abstract available


  128. BACHELET D, Hassler S, Mbogning C, Link J, et al
    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
    PLoS One. 2016;11:e0162752.
    PubMed     Text format     Abstract available


  129. ALROUGHANI R, Akhtar S, Ahmed S, Behbehani R, et al
    Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    PLoS One. 2016;11:e0165846.
    PubMed     Text format     Abstract available


  130. WANG X, Liu W, O'Donnell M, Lutgendorf S, et al
    Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    PLoS One. 2016;11:e0168772.
    PubMed     Text format     Abstract available


  131. PIVOT D, Debouverie M, Grzebyk M, Brassat D, et al
    Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    PLoS One. 2016;11:e0167556.
    PubMed     Text format     Abstract available


  132. MURIS AH, Smolders J, Rolf L, Klinkenberg LJ, et al
    Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
    PLoS One. 2016;11:e0156122.
    PubMed     Text format     Abstract available


  133. STAMILE C, Kocevar G, Cotton F, Durand-Dubief F, et al
    A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
    PLoS One. 2016;11:e0156405.
    PubMed     Text format     Abstract available


  134. DORONIN VB, Parkhomenko TA, Castellazzi M, Cesnik E, et al
    Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0154688.
    PubMed     Text format     Abstract available


  135. YASUI J, Kawasaki E, Tanaka S, Awata T, et al
    Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    PLoS One. 2016;11:e0155643.
    PubMed     Text format     Abstract available


  136. CHEN HH, Lin IC, Chen HJ, Yeh SY, et al
    Association of Herpes Zoster and Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0155175.
    PubMed     Text format     Abstract available


  137. LAIBLE M, Jarius S, Mackensen F, Schmidt-Bacher A, et al
    Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0155322.
    PubMed     Text format     Abstract available


  138. BEGGS CB, Magnano C, Belov P, Krawiecki J, et al
    Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0153960.
    PubMed     Text format     Abstract available


  139. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Text format     Abstract available


  140. LAMPRIANOU S, Gysemans C, Bou Saab J, Pontes H, et al
    Glibenclamide Prevents Diabetes in NOD Mice.
    PLoS One. 2016;11:e0168839.
    PubMed     Text format     Abstract available


  141. SALEHI Z, Doosti R, Beheshti M, Janzamin E, et al
    Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
    PLoS One. 2016;11:e0159565.
    PubMed     Text format     Abstract available


  142. BSTEH G, Ehling R, Lutterotti A, Hegen H, et al
    Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
    PLoS One. 2016;11:e0158978.
    PubMed     Text format     Abstract available


  143. VIROSTKO J, Hilmes M, Eitel K, Moore DJ, et al
    Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
    PLoS One. 2016;11:e0158825.
    PubMed     Text format     Abstract available


  144. LUIPPOLD G, Bedenik J, Voigt A, Grempler R, et al
    Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    PLoS One. 2016;11:e0156346.
    PubMed     Text format     Abstract available


  145. KARAMYAN A, Dunser MW, Wiebe DJ, Pilz G, et al
    Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
    PLoS One. 2016;11:e0155795.
    PubMed     Text format     Abstract available


    January 2015
  146. LI J, Xia Y, Liu T, Wang J, et al
    Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis.
    PLoS One. 2015;10:e0120440.
    PubMed     Text format     Abstract available


  147. BORNSEN L, Romme Christensen J, Ratzer R, Hedegaard C, et al
    Endogenous Interferon-beta-Inducible Gene Expression and Interferon-beta-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis.
    PLoS One. 2015;10:e0118830.
    PubMed     Text format     Abstract available


  148. DIAZ-VALENCIA PA, Bougneres P, Valleron AJ
    Covariation of the incidence of type 1 diabetes with country characteristics available in public databases.
    PLoS One. 2015;10:e0118298.
    PubMed     Text format     Abstract available


  149. MALHOTRA A, Gundel M, Rajput AM, Mevissen HT, et al
    Knowledge Retrieval from PubMed Abstracts and Electronic Medical Records with the Multiple Sclerosis Ontology.
    PLoS One. 2015;10:e0116718.
    PubMed     Text format     Abstract available


  150. RICIGLIANO VA, Handel AE, Sandve GK, Annibali V, et al
    EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
    PLoS One. 2015;10:e0119605.
    PubMed     Text format     Abstract available


  151. SONODA Y, Gohda T, Suzuki Y, Omote K, et al
    Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    PLoS One. 2015;10:e0122212.
    PubMed     Text format     Abstract available


  152. TAMBURO E, Varrica D, Dongarra G, Grimaldi LM, et al
    Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
    PLoS One. 2015;10:e0122142.
    PubMed     Text format     Abstract available


  153. MONDAL S, Pahan K
    Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
    PLoS One. 2015;10:e0116566.
    PubMed     Text format     Abstract available


  154. SUN Q, Zhang J, Zhou N, Liu X, et al
    DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.
    PLoS One. 2015;10:e0112305.
    PubMed     Text format     Abstract available


  155. PAN XF, Gu JQ, Shan ZY
    Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0123291.
    PubMed     Text format     Abstract available


  156. HEINZMANN D, Bangert A, Muller AM, von Ungern-Sternberg SN, et al
    The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
    PLoS One. 2015;10:e0124606.
    PubMed     Text format     Abstract available


  157. YILMAZ V, Oflazer P, Aysal F, Durmus H, et al
    Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
    PLoS One. 2015;10:e0123546.
    PubMed     Text format     Abstract available


  158. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  159. MA TT, Wang H, Wang C, Chang DY, et al
    Urinary levels of high mobility group box-1 are associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    PLoS One. 2015;10:e0123586.
    PubMed     Text format     Abstract available


  160. STELLMANN JP, Neuhaus A, Gotze N, Briken S, et al
    Ecological Validity of Walking Capacity Tests in Multiple Sclerosis.
    PLoS One. 2015;10:e0123822.
    PubMed     Text format     Abstract available


  161. MORITA M, Mii A, Shimizu A, Yasuda F, et al
    Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    PLoS One. 2015;10:e0116700.
    PubMed     Text format     Abstract available


  162. AHMADIAFSHAR A, Mohsenifard MR, Mazloomzadeh S
    Evaluation of Serum & Salivary IgA in Patients with Type 1 Diabetes.
    PLoS One. 2015;10:e0122757.
    PubMed     Text format     Abstract available


  163. TSIVGOULIS G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, et al
    The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0116511.
    PubMed     Text format     Abstract available


  164. SHIELDS SD, Butt RP, Dib-Hajj SD, Waxman SG, et al
    Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0119067.
    PubMed     Text format     Abstract available


  165. WU DH, Xu L, Wen CP, Xie GQ, et al
    The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
    PLoS One. 2015;10:e0118462.
    PubMed     Text format     Abstract available


  166. MONTI L, Donati D, Menci E, Cioni S, et al
    Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
    PLoS One. 2015;10:e0116681.
    PubMed     Text format     Abstract available


  167. BEAROFF F, Case LK, Krementsov DN, Wall EH, et al
    Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
    PLoS One. 2015;10:e0117993.
    PubMed     Text format     Abstract available


  168. STELLMANN JP, Sturner KH, Young KL, Siemonsen S, et al
    Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?
    PLoS One. 2015;10:e0116559.
    PubMed     Text format     Abstract available


  169. CHEN H, Zheng D, Ambadapadi S, Davids J, et al
    Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.
    PLoS One. 2015;10:e0115482.
    PubMed     Text format     Abstract available


  170. CRAWFORD GL, Boldison J, Copland DA, Adamson P, et al
    The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitis.
    PLoS One. 2015;10:e0122093.
    PubMed     Text format     Abstract available


  171. YOSSEF R, Gur C, Shemesh A, Guttman O, et al
    Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes.
    PLoS One. 2015;10:e0118936.
    PubMed     Text format     Abstract available


  172. HARMS RZ, Lorenzo KM, Corley KP, Cabrera MS, et al
    Altered CD161bright CD8+ Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics.
    PLoS One. 2015;10:e0117335.
    PubMed     Text format     Abstract available


  173. YE X, Zhang L, Wang H, Chen Y, et al
    The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia.
    PLoS One. 2015;10:e0117704.
    PubMed     Text format     Abstract available


  174. AL-RUBEAAN K, Al Derwish M, Ouizi S, Youssef AM, et al
    Diabetic foot complications and their risk factors from a large retrospective cohort study.
    PLoS One. 2015;10:e0124446.
    PubMed     Text format     Abstract available


  175. MOTL RW, Putzki N, Pilutti LA, Cadavid D, et al
    Longitudinal changes in self-reported walking ability in multiple sclerosis.
    PLoS One. 2015;10:e0125002.
    PubMed     Text format     Abstract available


  176. PELISCH N, Dan T, Ichimura A, Sekiguchi H, et al
    Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0124510.
    PubMed     Text format     Abstract available


  177. JIA XY, Cui Z, Li JN, Hu SY, et al
    Identification of critical residues of linear B cell epitope on Goodpasture autoantigen.
    PLoS One. 2015;10:e0123277.
    PubMed     Text format     Abstract available


  178. LUYET C, Schulze K, Sayar BS, Howald D, et al
    Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    PLoS One. 2015;10:e0119809.
    PubMed     Text format     Abstract available


  179. BOS SD, Page CM, Andreassen BK, Elboudwarej E, et al
    Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis.
    PLoS One. 2015;10:e0117403.
    PubMed     Text format     Abstract available


  180. ROMMLER F, Hammel M, Waldhuber A, Muller T, et al
    Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    PLoS One. 2015;10:e0116703.
    PubMed     Text format     Abstract available


  181. SHANG W, Ning Y, Xu X, Li M, et al
    Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    PLoS One. 2015;10:e0126016.
    PubMed     Text format     Abstract available


  182. GEVAERT T, Moles Lopez X, Sagaert X, Libbrecht L, et al
    Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.
    PLoS One. 2015;10:e0127020.
    PubMed     Text format     Abstract available


  183. CANDON S, Perez-Arroyo A, Marquet C, Valette F, et al
    Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.
    PLoS One. 2015;10:e0125448.
    PubMed     Text format     Abstract available


  184. PLADYS A, Couchoud C, LeGuillou A, Siebert M, et al
    Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39 811 French dialyzed patients.
    PLoS One. 2015;10:e0125089.
    PubMed     Text format     Abstract available


  185. KONNO S, Suzuki S, Masuda M, Nagane Y, et al
    Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study.
    PLoS One. 2015;10:e0126579.
    PubMed     Text format     Abstract available


  186. CHIUSO-MINICUCCI F, Ishikawa LL, Mimura LA, Fraga-Silva TF, et al
    Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2015;10:e0125836.
    PubMed     Text format     Abstract available


  187. CHEN Z, Lou X, Liu M, Huang D, et al
    Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
    PLoS One. 2015;10:e0126574.
    PubMed     Text format     Abstract available


  188. HU C, Huang W, Chen H, Song G, et al
    Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus.
    PLoS One. 2015;10:e0126643.
    PubMed     Text format     Abstract available


  189. WU CC, Huang YS, Chen JS, Huang CF, et al
    Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy.
    PLoS One. 2015;10:e0125726.
    PubMed     Text format     Abstract available


  190. VERINAUD L, Lopes SC, Prado IC, Zanucoli F, et al
    Violacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T Cells.
    PLoS One. 2015;10:e0125409.
    PubMed     Text format     Abstract available


  191. BORTOLIN RH, da Graca Azevedo Abreu BJ, Abbott Galvao Ururahy M, Costa de Souza KS, et al
    Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.
    PLoS One. 2015;10:e0125349.
    PubMed     Text format     Abstract available


  192. MURPHY SF, Schaeffer AJ, Done J, Wong L, et al
    IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
    PLoS One. 2015;10:e0125623.
    PubMed     Text format     Abstract available


  193. DU H, Shi L, Chen P, Yang W, et al
    Prohibitin Is Involved in Patients with IgG4 Related Disease.
    PLoS One. 2015;10:e0125331.
    PubMed     Text format     Abstract available


  194. RAKUSA M, Cano SJ, Porter B, Riazi A, et al
    A predictive model for corticosteroid response in individual patients with MS relapses.
    PLoS One. 2015;10:e0120829.
    PubMed     Text format     Abstract available


  195. AYZENBERG I, Schlevogt S, Metzdorf J, Stahlke S, et al
    Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging.
    PLoS One. 2015;10:e0118550.
    PubMed     Text format     Abstract available


  196. KIM YU, Lim H, Jung HE, Wetsel RA, et al
    Regulation of autoimmune germinal center reactions in lupus-prone BXD2 mice by follicular helper T cells.
    PLoS One. 2015;10:e0120294.
    PubMed     Text format     Abstract available


  197. HIRAKAWA H, Zempo H, Ogawa M, Watanabe R, et al
    A DPP-4 inhibitor suppresses fibrosis and inflammation on experimental autoimmune myocarditis in mice.
    PLoS One. 2015;10:e0119360.
    PubMed     Text format     Abstract available


  198. ZHONG Y, Wang K, Zhang X, Cai X, et al
    Nephrokeli, a Chinese herbal formula, may improve IgA nephropathy through regulation of the sphingosine-1-phosphate pathway.
    PLoS One. 2015;10:e0116873.
    PubMed     Text format     Abstract available


  199. WANG H, Sun L, Tan W
    Clinical features of children with pulmonary microscopic polyangiitis: report of 9 cases.
    PLoS One. 2015;10:e0124352.
    PubMed     Text format     Abstract available


  200. KUEHL MN, Rodriguez H, Burkhardt BR, Alman AC, et al
    Tumor Necrosis Factor-alpha, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects.
    PLoS One. 2015;10:e0125320.
    PubMed     Text format     Abstract available


  201. BONEPARTH A, Huang W, Bethunaickan R, Woods M, et al
    TLR7 influences germinal center selection in murine SLE.
    PLoS One. 2015;10:e0119925.
    PubMed     Text format     Abstract available


  202. BURKE SD, Seaward AV, Ramshaw H, Smith GN, et al
    Homing Receptor Expression Is Deviated on CD56+ Blood Lymphocytes during Pregnancy in Type 1 Diabetic Women.
    PLoS One. 2015;10:e0119526.
    PubMed     Text format     Abstract available


  203. FAN ZD, Wang FF, Huang H, Huang N, et al
    STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C polymorphisms influence the risk of developing juvenile idiopathic arthritis in Han Chinese patients.
    PLoS One. 2015;10:e0117389.
    PubMed     Text format     Abstract available


  204. BESTER M, Forkert ND, Stellmann JP, Aly L, et al
    Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
    PLoS One. 2015;10:e0119356.
    PubMed     Text format     Abstract available


  205. NAKAJIMA A, Masaki Y, Nakamura T, Kawanami T, et al
    Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
    PLoS One. 2015;10:e0126582.
    PubMed     Text format     Abstract available


  206. TSYMBALIUK I, Unukovych D, Shvets N, Dinets A, et al
    Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine.
    PLoS One. 2015;10:e0122388.
    PubMed     Text format     Abstract available


  207. MITCHELL AL, Boe Wolff A, MacArthur K, Weaver JU, et al
    Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.
    PLoS One. 2015;10:e0123550.
    PubMed     Text format     Abstract available


  208. TOLLEY K, Hutchinson M, You X, Wang P, et al
    A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2015;10:e0127960.
    PubMed     Text format     Abstract available


  209. HEINE M, van den Akker LE, Verschuren O, Visser-Meily A, et al
    Reliability and Responsiveness of Cardiopulmonary Exercise Testing in Fatigued Persons with Multiple Sclerosis and Low to Mild Disability.
    PLoS One. 2015;10:e0122260.
    PubMed     Text format     Abstract available


  210. HSIN YC, Zhuang LZ, Yeh KW, Chang CW, et al
    Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2015;10:e0128768.
    PubMed     Text format     Abstract available


  211. JARAZO DIETRICH S, Fass MI, Jacobo PV, Sobarzo CM, et al
    Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion.
    PLoS One. 2015;10:e0128709.
    PubMed     Text format     Abstract available


  212. LIU Y, Ye J, Shin Ogawa L, Inoue T, et al
    The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.
    PLoS One. 2015;10:e0127361.
    PubMed     Text format     Abstract available


  213. HARRIS TL, McGargill MA
    Drak2 Does Not Regulate TGF-beta Signaling in T Cells.
    PLoS One. 2015;10:e0123650.
    PubMed     Text format     Abstract available


  214. ZHAO Y, Zhu L, Zhou T, Zhang Q, et al
    Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    PLoS One. 2015;10:e0119033.
    PubMed     Text format     Abstract available


  215. RAMBERGER M, Peschl P, Schanda K, Irschick R, et al
    Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay.
    PLoS One. 2015;10:e0122037.
    PubMed     Text format     Abstract available


  216. HAYASHI T, Yao S, Crain B, Promessi VJ, et al
    Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.
    PLoS One. 2015;10:e0129867.
    PubMed     Text format     Abstract available


  217. ALLAN ER, Yates RM
    Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2015;10:e0128945.
    PubMed     Text format     Abstract available


  218. SOLTI I, Kvell K, Talaber G, Veto S, et al
    Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0129217.
    PubMed     Text format     Abstract available


  219. RIBBONS KA, McElduff P, Boz C, Trojano M, et al
    Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
    PLoS One. 2015;10:e0122686.
    PubMed     Text format     Abstract available


  220. BATES MA, Brandenberger C, Langohr I, Kumagai K, et al
    Silica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse.
    PLoS One. 2015;10:e0125481.
    PubMed     Text format     Abstract available


  221. DEJACO C, Oppl B, Monach P, Cuthbertson D, et al
    Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    PLoS One. 2015;10:e0121737.
    PubMed     Text format     Abstract available


  222. SHIMIZU F, Nishihara H, Sano Y, Takeshita Y, et al
    Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
    PLoS One. 2015;10:e0122000.
    PubMed     Text format     Abstract available


  223. KLISTORNER A, Vootakuru N, Wang C, Yiannikas C, et al
    Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
    PLoS One. 2015;10:e0122114.
    PubMed     Text format     Abstract available



  224. Correction: direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
    PLoS One. 2015;10:e0120947.
    PubMed     Text format    


  225. LALWANI P, de Souza GK, de Lima DS, Passos LF, et al
    Serum thiols as a biomarker of disease activity in lupus nephritis.
    PLoS One. 2015;10:e0119947.
    PubMed     Text format     Abstract available


  226. DEL PICCOLO L, Pietrolongo E, Radice D, Tortorella C, et al
    Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
    PLoS One. 2015;10:e0127734.
    PubMed     Text format     Abstract available


  227. CRUZ Y, Lorea J, Mestre H, Kim-Lee JH, et al
    Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
    PLoS One. 2015;10:e0121854.
    PubMed     Text format     Abstract available


  228. PATTI F, De Stefano M, Lavorgna L, Messina S, et al
    Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    PLoS One. 2015;10:e0120754.
    PubMed     Text format     Abstract available


  229. HAWRO T, Bogucki A, Krupinska-Kun M, Maurer M, et al
    Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-beta2GPI Antibodies in Patients with Systemic Lupus Erythematosus.
    PLoS One. 2015;10:e0119911.
    PubMed     Text format     Abstract available


  230. MATTIOLI F, Stampatori C, Bellomi F, Scarpazza C, et al
    Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
    PLoS One. 2015;10:e0131803.
    PubMed     Text format     Abstract available


  231. MENG Q, Xin L, Liu W, Lin H, et al
    Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review.
    PLoS One. 2015;10:e0130466.
    PubMed     Text format     Abstract available


  232. ANDREASSEN OA, Desikan RS, Wang Y, Thompson WK, et al
    Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms.
    PLoS One. 2015;10:e0123057.
    PubMed     Text format     Abstract available


  233. PETROPOULOS IN, Green P, Chan AW, Alam U, et al
    Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria.
    PLoS One. 2015;10:e0123517.
    PubMed     Text format     Abstract available


  234. LIAO X, Ren J, Wei CH, Ross AC, et al
    Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
    PLoS One. 2015;10:e0118176.
    PubMed     Text format     Abstract available


  235. ALLIZOND V, Scutera S, Rossi S, Musso T, et al
    Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.
    PLoS One. 2015;10:e0131557.
    PubMed     Text format     Abstract available


  236. FINDLING O, Baltisberger M, Jung S, Kamm CP, et al
    Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
    PLoS One. 2015;10:e0121856.
    PubMed     Text format     Abstract available


  237. ZHORNITSKY S, Greenfield J, Koch MW, Patten SB, et al
    Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.
    PLoS One. 2015;10:e0123824.
    PubMed     Text format     Abstract available


  238. VESTERINEN HM, Connick P, Irvine CM, Sena ES, et al
    Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
    PLoS One. 2015;10:e0117705.
    PubMed     Text format     Abstract available


  239. AEINEHBAND S, Lindblom RP, Al Nimer F, Vijayaraghavan S, et al
    Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
    PLoS One. 2015;10:e0122048.
    PubMed     Text format     Abstract available


  240. SIMPFENDORFER KR, Strugnell RA, Brodnicki TC, Wijburg OL, et al
    Increased Autoimmune Diabetes in pIgR-Deficient NOD Mice Is Due to a "Hitchhiking" Interval that Refines the Genetic Effect of Idd5.4.
    PLoS One. 2015;10:e0121979.
    PubMed     Text format     Abstract available


  241. BACHLE C, Lange K, Stahl-Pehe A, Castillo K, et al
    Symptoms of Eating Disorders and Depression in Emerging Adults with Early-Onset, Long-Duration Type 1 Diabetes and Their Association with Metabolic Control.
    PLoS One. 2015;10:e0131027.
    PubMed     Text format     Abstract available


  242. MANCUSO R, Hernis A, Agostini S, Rovaris M, et al
    Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis.
    PLoS One. 2015;10:e0130715.
    PubMed     Text format     Abstract available


  243. RONDA MC, Dijkhorst-Oei LT, Rutten GE
    Patients' Experiences with and Attitudes towards a Diabetes Patient Web Portal.
    PLoS One. 2015;10:e0129403.
    PubMed     Text format     Abstract available


  244. PERGA S, Giuliano Albo A, Lis K, Minari N, et al
    Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
    PLoS One. 2015;10:e0129291.
    PubMed     Text format     Abstract available


  245. JACOBSEN R, Hypponen E, Sorensen TI, Vaag AA, et al
    Gestational and Early Infancy Exposure to Margarine Fortified with Vitamin D through a National Danish Programme and the Risk of Type 1 Diabetes: The D-Tect Study.
    PLoS One. 2015;10:e0128631.
    PubMed     Text format     Abstract available


  246. NATHOO N, Rogers JA, Yong VW, Dunn JF, et al
    Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
    PLoS One. 2015;10:e0127033.
    PubMed     Text format     Abstract available


  247. NAGHAVIAN R, Ghaedi K, Kiani-Esfahani A, Ganjalikhani-Hakemi M, et al
    miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
    PLoS One. 2015;10:e0124555.
    PubMed     Text format     Abstract available


  248. FRANCESCATO MP, Stel G, Stenner E, Geat M, et al
    Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances.
    PLoS One. 2015;10:e0125220.
    PubMed     Text format     Abstract available


  249. STILUND M, Gjelstrup MC, Petersen T, Moller HJ, et al
    Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
    PLoS One. 2015;10:e0119681.
    PubMed     Text format     Abstract available


  250. LERAY E, Vukusic S, Debouverie M, Clanet M, et al
    Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
    PLoS One. 2015;10:e0132033.
    PubMed     Text format     Abstract available


  251. WANG N, Rajasekaran N, Hou T, Macaubas C, et al
    Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.
    PLoS One. 2015;10:e0128494.
    PubMed     Text format     Abstract available


  252. KAUR K, Zheng NY, Smith K, Huang M, et al
    High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.
    PLoS One. 2015;10:e0125618.
    PubMed     Text format     Abstract available


  253. BADR G, Sayed A, Abdel-Maksoud MA, Mohamed AO, et al
    Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFkappaB and ERK.
    PLoS One. 2015;10:e0125340.
    PubMed     Text format     Abstract available


  254. MALLI C, Pandit L, D'Cunha A, Mustafa S, et al
    Environmental factors related to multiple sclerosis in Indian population.
    PLoS One. 2015;10:e0124064.
    PubMed     Text format     Abstract available


  255. BENCHIMOL EI, Manuel DG, To T, Mack DR, et al
    Asthma, Type 1 and Type 2 Diabetes Mellitus, and Inflammatory Bowel Disease amongst South Asian Immigrants to Canada and Their Children: A Population-Based Cohort Study.
    PLoS One. 2015;10:e0123599.
    PubMed     Text format     Abstract available


  256. BOZIN I, Ge Y, Kuchling J, Dusek P, et al
    Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
    PLoS One. 2015;10:e0128386.
    PubMed     Text format     Abstract available


  257. BENDAS A, Rothe U, Kiess W, Kapellen TM, et al
    Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in GERMANY - Model-Based National Estimates.
    PLoS One. 2015;10:e0132716.
    PubMed     Text format     Abstract available


  258. AKKAD DA, Olischewsky A, Reiner F, Hellwig K, et al
    Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.
    PLoS One. 2015;10:e0127632.
    PubMed     Text format     Abstract available


  259. FAVARETTO A, Poggiali D, Lazzarotto A, Rolma G, et al
    The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset.
    PLoS One. 2015;10:e0127805.
    PubMed     Text format     Abstract available


  260. OGUCHI T, Ota M, Ito T, Hamano H, et al
    Investigation of susceptibility genes triggering lachrymal/salivary gland lesion complications in Japanese patients with type 1 autoimmune pancreatitis.
    PLoS One. 2015;10:e0127078.
    PubMed     Text format     Abstract available


  261. YANG C, Fei Y, Qin Y, Luo D, et al
    Bacterial Flora Changes in Conjunctiva of Rats with Streptozotocin-Induced Type I Diabetes.
    PLoS One. 2015;10:e0133021.
    PubMed     Text format     Abstract available


  262. DOMINGUETI CP, Dusse LM, Foscolo RB, Reis JS, et al
    Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
    PLoS One. 2015;10:e0132784.
    PubMed     Text format     Abstract available


  263. ZHUANG Y, Zhou F, Gong H
    Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis.
    PLoS One. 2015;10:e0130524.
    PubMed     Text format     Abstract available


  264. VAN DER HIELE K, van Gorp D, Ruimschotel R, Kamminga N, et al
    Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2015;10:e0129228.
    PubMed     Text format     Abstract available


  265. SHIELDS EJ, Lam CJ, Cox AR, Rankin MM, et al
    Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes.
    PLoS One. 2015;10:e0129809.
    PubMed     Text format     Abstract available


  266. TEJERA-ALHAMBRA M, Casrouge A, de Andres C, Seyfferth A, et al
    Plasma biomarkers discriminate clinical forms of multiple sclerosis.
    PLoS One. 2015;10:e0128952.
    PubMed     Text format     Abstract available


  267. HYUN JW, Kim SH, Jeong IH, Ahn SW, et al
    Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
    PLoS One. 2015;10:e0129243.
    PubMed     Text format     Abstract available


  268. KORNETE M, Mason ES, Girouard J, Lafferty EI, et al
    Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to beta-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    PLoS One. 2015;10:e0126311.
    PubMed     Text format     Abstract available


  269. AVSAR T, Durasi IM, Uygunoglu U, Tutuncu M, et al
    CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.
    PLoS One. 2015;10:e0122045.
    PubMed     Text format     Abstract available


  270. EHLER J, Koball S, Sauer M, Mitzner S, et al
    Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
    PLoS One. 2015;10:e0134583.
    PubMed     Text format     Abstract available


  271. FAN X, Jin T, Zhao S, Liu C, et al
    Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.
    PLoS One. 2015;10:e0134523.
    PubMed     Text format     Abstract available


  272. HAUROGNE K, Pavlovic M, Rogniaux H, Bach JM, et al
    Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes.
    PLoS One. 2015;10:e0134365.
    PubMed     Text format     Abstract available


  273. HANSEN K, Schussel K, Kieble M, Werning J, et al
    Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
    PLoS One. 2015;10:e0133279.
    PubMed     Text format     Abstract available


  274. SEVERIJNS D, Octavia JR, Kerkhofs L, Coninx K, et al
    Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
    PLoS One. 2015;10:e0133729.
    PubMed     Text format     Abstract available


  275. ANDERSSON DP, Ekstrom U, Lehtihet M
    Rigiscan Evaluation of Men with Diabetes Mellitus and Erectile Dysfunction and Correlation with Diabetes Duration, Age, BMI, Lipids and HbA1c.
    PLoS One. 2015;10:e0133121.
    PubMed     Text format     Abstract available


  276. AL-SHAMMRI SN, Hanna MG, Chattopadhyay A, Akanji AO, et al
    Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
    PLoS One. 2015;10:e0132106.
    PubMed     Text format     Abstract available


  277. PUJOL-AUTONELL I, Serracant-Prat A, Cano-Sarabia M, Ampudia RM, et al
    Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
    PLoS One. 2015;10:e0127057.
    PubMed     Text format     Abstract available


  278. BRUGNARA L, Mallol R, Ribalta J, Vinaixa M, et al
    Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy.
    PLoS One. 2015;10:e0136348.
    PubMed     Text format     Abstract available


  279. MOSER O, Tschakert G, Mueller A, Groeschl W, et al
    Effects of High-Intensity Interval Exercise versus Moderate Continuous Exercise on Glucose Homeostasis and Hormone Response in Patients with Type 1 Diabetes Mellitus Using Novel Ultra-Long-Acting Insulin.
    PLoS One. 2015;10:e0136489.
    PubMed     Text format     Abstract available


  280. BURCH TC, Morris MA, Campbell-Thompson M, Pugliese A, et al
    Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes.
    PLoS One. 2015;10:e0135663.
    PubMed     Text format     Abstract available


  281. SCHEUING N, Wiegand S, Bachle C, Frohlich-Reiterer E, et al
    Impact of Maternal Country of Birth on Type-1-Diabetes Therapy and Outcome in 27,643 Children and Adolescents from the DPV Registry.
    PLoS One. 2015;10:e0135178.
    PubMed     Text format     Abstract available


  282. BERTOLI D, Serana F, Sottini A, Cordioli C, et al
    Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.
    PLoS One. 2015;10:e0135441.
    PubMed     Text format     Abstract available


  283. NYGAARD GO, Celius EG, de Rodez Benavent SA, Sowa P, et al
    A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.
    PLoS One. 2015;10:e0135974.
    PubMed     Text format     Abstract available


  284. ORTIZ MA, Nunez C, Ordonez D, Alvarez-Cermeno JC, et al
    Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
    PLoS One. 2015;10:e0134414.
    PubMed     Text format     Abstract available


  285. GENNARO G, Claudino M, Cestari TM, Ceolin D, et al
    Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats.
    PLoS One. 2015;10:e0134784.
    PubMed     Text format     Abstract available


  286. CALABRESE M, Reynolds R, Magliozzi R, Castellaro M, et al
    Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
    PLoS One. 2015;10:e0135428.
    PubMed     Text format     Abstract available


  287. MADDALONI E, Lessan N, Al Tikriti A, Buzzetti R, et al
    Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
    PLoS One. 2015;10:e0131837.
    PubMed     Text format     Abstract available


  288. MALYAVANTHAM K, Weinstock-Guttman B, Suresh L, Zivadinov R, et al
    Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
    PLoS One. 2015;10:e0129503.
    PubMed     Text format     Abstract available


  289. VENKATARAMAN K, Tan LS, Bautista DC, Griva K, et al
    Psychometric Properties of the Problem Areas in Diabetes (PAID) Instrument in Singapore.
    PLoS One. 2015;10:e0136759.
    PubMed     Text format     Abstract available


  290. SUGIMOTO M, Takagi T, Suzuki R, Konno N, et al
    Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study.
    PLoS One. 2015;10:e0138604.
    PubMed     Text format     Abstract available


  291. MATTHEWS L, Kolind S, Brazier A, Leite MI, et al
    Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
    PLoS One. 2015;10:e0137715.
    PubMed     Text format     Abstract available


  292. IONESCU-TIRGOVISTE C, Gagniuc PA, Guja C
    Structural Properties of Gene Promoters Highlight More than Two Phenotypes of Diabetes.
    PLoS One. 2015;10:e0137950.
    PubMed     Text format     Abstract available


  293. MAZZARA S, Sinisi A, Cardaci A, Rossi RL, et al
    Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis.
    PLoS One. 2015;10:e0137927.
    PubMed     Text format     Abstract available


  294. BISCHOF J, Muller S, Borufka L, Asghari F, et al
    Quantitative Trait Locus Analysis Implicates CD4+/CD44high Memory T Cells in the Pathogenesis of Murine Autoimmune Pancreatitis.
    PLoS One. 2015;10:e0136298.
    PubMed     Text format     Abstract available


  295. LEE AC, Lam JK, Shiu SW, Wong Y, et al
    Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
    PLoS One. 2015;10:e0137330.
    PubMed     Text format     Abstract available


  296. MOUZAKI A, Rodi M, Dimisianos N, Emmanuil A, et al
    Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    PLoS One. 2015;10:e0135434.
    PubMed     Text format     Abstract available


  297. GAUTIER JF, Porcher R, Abi Khalil C, Bellili-Munoz N, et al
    Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is Associated with Alterations in Genome-Wide DNA Methylation.
    PLoS One. 2015;10:e0134654.
    PubMed     Text format     Abstract available


  298. LEIKFOSS IS, Keshari PK, Gustavsen MW, Bjolgerud A, et al
    Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
    PLoS One. 2015;10:e0132957.
    PubMed     Text format     Abstract available


  299. CHOI JH, Lee MJ, Jang M, Kim EJ, et al
    An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    PLoS One. 2015;10:e0138592.
    PubMed     Text format     Abstract available


  300. WENS I, Dalgas U, Vandenabeele F, Grevendonk L, et al
    High Intensity Exercise in Multiple Sclerosis: Effects on Muscle Contractile Characteristics and Exercise Capacity, a Randomised Controlled Trial.
    PLoS One. 2015;10:e0133697.
    PubMed     Text format     Abstract available


  301. ZIEMSSEN T, Rauer S, Stadelmann C, Henze T, et al
    Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
    PLoS One. 2015;10:e0138243.
    PubMed     Text format     Abstract available


  302. JONKMAN LE, Rosenthal DM, Sormani MP, Miles L, et al
    Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
    PLoS One. 2015;10:e0129380.
    PubMed     Text format     Abstract available


  303. CARVALHO-SANTOS A, Ribeiro-Alves M, Cardoso-Weide LC, Nunes J, et al
    Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.
    PLoS One. 2015;10:e0140150.
    PubMed     Text format     Abstract available


  304. RYNINKS K, Sutton E, Thomas E, Jago R, et al
    Attitudes to Exercise and Diabetes in Young People with Type 1 Diabetes Mellitus: A Qualitative Analysis.
    PLoS One. 2015;10:e0137562.
    PubMed     Text format     Abstract available


  305. LLAURADO G, Megia A, Cano A, Gimenez-Palop O, et al
    FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness.
    PLoS One. 2015;10:e0140222.
    PubMed     Text format     Abstract available


  306. ABRAHAM A, Alabdali M, Qrimli M, Albulaihe H, et al
    Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
    PLoS One. 2015;10:e0139674.
    PubMed     Text format     Abstract available


  307. NIELSEN HH, Beck HC, Kristensen LP, Burton M, et al
    The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
    PLoS One. 2015;10:e0139659.
    PubMed     Text format     Abstract available


  308. HEESEN C, Kasper J, Fischer K, Kopke S, et al
    Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions.
    PLoS One. 2015;10:e0138364.
    PubMed     Text format     Abstract available


  309. CHEN M, Tian X, Qin F, Zhou J, et al
    Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death.
    PLoS One. 2015;10:e0139144.
    PubMed     Text format     Abstract available


  310. ARAVINDHAN V, Mohan V, Arunkumar N, Sandhya S, et al
    Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.
    PLoS One. 2015;10:e0137618.
    PubMed     Text format     Abstract available


  311. NWOSU BU, Maranda L, Cullen K, Greenman L, et al
    A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
    PLoS One. 2015;10:e0137525.
    PubMed     Text format     Abstract available


  312. LOPEZ-GONGORA M, Escartin A, Martinez-Horta S, Fernandez-Bobadilla R, et al
    Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
    PLoS One. 2015;10:e0136786.
    PubMed     Text format     Abstract available


  313. LAMARGUE HAMEL D, Deloire M, Ruet A, Charre-Morin J, et al
    Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.
    PLoS One. 2015;10:e0142152.
    PubMed     Text format     Abstract available


  314. PERKINS BA, Cherney DZ, Soleymanlou N, Lee JA, et al
    Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
    PLoS One. 2015;10:e0141085.
    PubMed     Text format     Abstract available


  315. AL-TEMAIMI RA, Al-Enezi A, Al-Serri A, Al-Roughani R, et al
    The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
    PLoS One. 2015;10:e0142265.
    PubMed     Text format     Abstract available


  316. OSTROVSKI I, Lovblom LE, Farooqi MA, Scarr D, et al
    Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy.
    PLoS One. 2015;10:e0142309.
    PubMed     Text format     Abstract available


  317. WISTING L, Bang L, Skrivarhaug T, Dahl-Jorgensen K, et al
    Adolescents with Type 1 Diabetes - The Impact of Gender, Age, and Health-Related Functioning on Eating Disorder Psychopathology.
    PLoS One. 2015;10:e0141386.
    PubMed     Text format     Abstract available


  318. SELVARAJAH D, Cash T, Davies J, Sankar A, et al
    SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy.
    PLoS One. 2015;10:e0138224.
    PubMed     Text format     Abstract available


  319. ELEK Z, Nemeth N, Nagy G, Nemeth H, et al
    Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus.
    PLoS One. 2015;10:e0139519.
    PubMed     Text format     Abstract available


  320. THALER C, Faizy T, Sedlacik J, Holst B, et al
    T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    PLoS One. 2015;10:e0144693.
    PubMed     Text format     Abstract available


  321. MITSUISHI S, Nishimura R, Ando K, Tsujino D, et al
    Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
    PLoS One. 2015;10:e0144041.
    PubMed     Text format     Abstract available


  322. HANSEN L, Schmidt-Christensen A, Gupta S, Fransen-Pettersson N, et al
    E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes.
    PLoS One. 2015;10:e0144090.
    PubMed     Text format     Abstract available


  323. ASSAYAG-ASHERIE N, Sever D, Bogdani M, Johnson P, et al
    Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes.
    PLoS One. 2015;10:e0143589.
    PubMed     Text format     Abstract available


  324. KANNEL K, Alnek K, Vahter L, Gross-Paju K, et al
    Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
    PLoS One. 2015;10:e0143393.
    PubMed     Text format     Abstract available


  325. VAN NOORT JM, Bsibsi M, Nacken PJ, Verbeek R, et al
    Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
    PLoS One. 2015;10:e0143366.
    PubMed     Text format     Abstract available


  326. AN HAACK I, Derkow K, Riehn M, Rentinck MN, et al
    The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
    PLoS One. 2015;10:e0143715.
    PubMed     Text format     Abstract available


  327. GAGLIANI N, Jofra T, Posgai AL, Atkinson MA, et al
    Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
    PLoS One. 2015;10:e0142318.
    PubMed     Text format     Abstract available


  328. MIGITA K, Komori A, Kozuru H, Jiuchi Y, et al
    Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
    PLoS One. 2015;10:e0136908.
    PubMed     Text format     Abstract available


  329. VALERA P, Zavattari P, Sanna A, Pretti S, et al
    Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island.
    PLoS One. 2015;10:e0141262.
    PubMed     Text format     Abstract available


  330. ALONSO N, Julian MT, Carrascal J, Colobran R, et al
    Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8+T Effector Memory Subset.
    PLoS One. 2015;10:e0142186.
    PubMed     Text format     Abstract available


  331. SAMUVEL DJ, Saxena N, Dhindsa JS, Singh AK, et al
    AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0141781.
    PubMed     Text format     Abstract available


  332. MIYAKE S, Kim S, Suda W, Oshima K, et al
    Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.
    PLoS One. 2015;10:e0137429.
    PubMed     Text format     Abstract available


  333. MARIA Z, Campolo AR, Lacombe VA
    Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.
    PLoS One. 2015;10:e0146033.
    PubMed     Text format     Abstract available


  334. KAVALIUNAS A, Wiberg M, Tinghog P, Glaser A, et al
    Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
    PLoS One. 2015;10:e0145435.
    PubMed     Text format     Abstract available


  335. REPPE S, Wang Y, Thompson WK, McEvoy LK, et al
    Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci.
    PLoS One. 2015;10:e0144531.
    PubMed     Text format     Abstract available


  336. SANTOS CM, Lira-Junior R, Fischer RG, Santos AP, et al
    Systemic Antibiotics in Periodontal Treatment of Diabetic Patients: A Systematic Review.
    PLoS One. 2015;10:e0145262.
    PubMed     Text format     Abstract available


  337. WANG D, Shanina I, Toyofuku WM, Horwitz MS, et al
    Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy.
    PLoS One. 2015;10:e0145179.
    PubMed     Text format     Abstract available


  338. TSIVGOULIS G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, et al
    The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0144538.
    PubMed     Text format     Abstract available


  339. ALNEK K, Kisand K, Heilman K, Peet A, et al
    Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.
    PLoS One. 2015;10:e0142976.
    PubMed     Text format     Abstract available


  340. VARGA BE, Gao W, Laurik KL, Tatrai E, et al
    Investigating Tissue Optical Properties and Texture Descriptors of the Retina in Patients with Multiple Sclerosis.
    PLoS One. 2015;10:e0143711.
    PubMed     Text format     Abstract available


  341. TERASAKI M, Hiromura M, Mori Y, Kohashi K, et al
    Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.
    PLoS One. 2015;10:e0143396.
    PubMed     Text format     Abstract available


  342. MAKSHAKOV G, Nazarov V, Kochetova O, Surkova E, et al
    Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    PLoS One. 2015;10:e0143375.
    PubMed     Text format     Abstract available


  343. FORNARI TA, Donate PB, Assis AF, Macedo C, et al
    Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
    PLoS One. 2015;10:e0142688.
    PubMed     Text format     Abstract available


  344. ABOULENEIN-DJAMSHIDIAN F, Krssak M, Serbecic N, Rauschka H, et al
    CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
    PLoS One. 2015;10:e0142272.
    PubMed     Text format     Abstract available


  345. RUGHOOPUTH MS, Zeng R, Yao Y
    Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate.
    PLoS One. 2015;10:e0145505.
    PubMed     Text format     Abstract available


  346. SALHEEN SM, Panchapakesan U, Pollock CA, Woodman OL, et al
    The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose.
    PLoS One. 2015;10:e0143941.
    PubMed     Text format     Abstract available


    January 2014
  347. AHLGREN C, Oden A, Lycke J
    High nationwide incidence of multiple sclerosis in sweden.
    PLoS One. 2014;9:e108599.
    PubMed     Text format     Abstract available


  348. WENS I, Dalgas U, Vandenabeele F, Krekels M, et al
    Multiple sclerosis affects skeletal muscle characteristics.
    PLoS One. 2014;9:e108158.
    PubMed     Text format     Abstract available


  349. LASCAR N, Kennedy A, Hancock B, Jenkins D, et al
    Attitudes and Barriers to Exercise in Adults with Type 1 Diabetes (T1DM) and How Best to Address Them: A Qualitative Study.
    PLoS One. 2014;9:e108019.
    PubMed     Text format     Abstract available


  350. BOE LUNDE HM, Telstad W, Grytten N, Kyte L, et al
    Employment among Patients with Multiple Sclerosis-A Population Study.
    PLoS One. 2014;9:e103317.
    PubMed     Text format     Abstract available


  351. BESSHO M, Murase-Mishiba Y, Imagawa A, Terasaki J, et al
    Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel alpha-Cell Model of Insulin-Deficient Diabetes.
    PLoS One. 2014;9:e113254.
    PubMed     Text format     Abstract available


  352. BORREANI C, Bianchi E, Pietrolongo E, Rossi I, et al
    Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.
    PLoS One. 2014;9:e109679.
    PubMed     Text format     Abstract available


  353. PINHAS-HAMIEL O, Hamiel U, Boyko V, Graph-Barel C, et al
    Trajectories of HbA1c Levels in Children and Youth with Type 1 Diabetes.
    PLoS One. 2014;9:e109109.
    PubMed     Text format     Abstract available


  354. KOEHRER P, Saab S, Berdeaux O, Isaico R, et al
    Erythrocyte phospholipid and polyunsaturated Fatty Acid composition in diabetic retinopathy.
    PLoS One. 2014;9:e106912.
    PubMed     Text format     Abstract available


  355. CAMINITI F, De Salvo S, De Cola MC, Russo M, et al
    Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
    PLoS One. 2014;9:e103151.
    PubMed     Text format     Abstract available


  356. KHSHEIBUN R, Paperna T, Volkowich A, Lejbkowicz I, et al
    Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.
    PLoS One. 2014;9:e102331.
    PubMed     Text format     Abstract available


  357. PETERSON A, Hanberger L, Akesson K, Bojestig M, et al
    Improved results in paediatric diabetes care using a quality registry in an improvement collaborative: a case study in sweden.
    PLoS One. 2014;9:e97875.
    PubMed     Text format     Abstract available


  358. CRIMI A, Commowick O, Maarouf A, Ferre JC, et al
    Predictive Value of Imaging Markers at Multiple Sclerosis Disease Onset Based on Gadolinium- and USPIO-Enhanced MRI and Machine Learning.
    PLoS One. 2014;9:e93024.
    PubMed     Text format     Abstract available


  359. LLUFRIU S, Sepulveda M, Blanco Y, Marin P, et al
    Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
    PLoS One. 2014;9:e113936.
    PubMed     Text format     Abstract available


  360. LUNG TW, Hayes AJ, Herman WH, Si L, et al
    A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality.
    PLoS One. 2014;9:e113635.
    PubMed     Text format     Abstract available


  361. MULS N, Dang HA, Sindic CJ, van Pesch V, et al
    Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
    PLoS One. 2014;9:e113025.
    PubMed     Text format     Abstract available


  362. GIANCHECCHI E, Crino A, Giorda E, Luciano R, et al
    Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis.
    PLoS One. 2014;9:e110755.
    PubMed     Text format     Abstract available


  363. VAN BELLE TL, Vanherwegen AS, Feyaerts D, De Clercq P, et al
    1,25-Dihydroxyvitamin D3 and Its Analog TX527 Promote a Stable Regulatory T Cell Phenotype in T Cells from Type 1 Diabetes Patients.
    PLoS One. 2014;9:e109194.
    PubMed     Text format     Abstract available


  364. LIU Y, Gupta P, Lapointe M, Yotsapon T, et al
    Acylation stimulating protein, complement c3 and lipid metabolism in ketosis-prone diabetic subjects.
    PLoS One. 2014;9:e109237.
    PubMed     Text format     Abstract available


  365. MIYAZAKI Y, Li R, Rezk A, Misirliyan H, et al
    A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2014;9:e105421.
    PubMed     Text format     Abstract available


  366. MANCINI M, Lanzillo R, Liuzzi R, Di Donato O, et al
    Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
    PLoS One. 2014;9:e92730.
    PubMed     Text format     Abstract available


  367. SONG ZY, Yamasaki R, Kawano Y, Sato S, et al
    Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
    PLoS One. 2015;10:e0124923.
    PubMed     Text format     Abstract available


  368. MATAS E, Bau L, Martinez-Iniesta M, Romero-Pinel L, et al
    Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
    PLoS One. 2014;9:e112758.
    PubMed     Text format     Abstract available


  369. HADJIGEORGIOU G, Dardiotis E, Tsivgoulis G, Doskas T, et al
    Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA).
    PLoS One. 2014;9:e113933.
    PubMed     Text format     Abstract available


  370. ZIVADINOV R, Dwyer MG, Markovic-Plese S, Kennedy C, et al
    Effect of treatment with interferon Beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
    PLoS One. 2014;9:e91098.
    PubMed     Text format     Abstract available


  371. MASSACESI L, Tramacere I, Amoroso S, Battaglia MA, et al
    Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
    PLoS One. 2014;9:e113371.
    PubMed     Text format     Abstract available


  372. ORTEGA-MADUENO I, Garcia-Montojo M, Dominguez-Mozo MI, Garcia-Martinez A, et al
    Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
    PLoS One. 2014;9:e104836.
    PubMed     Text format     Abstract available


  373. MARO JC, Fryback DG, Lieu TA, Lee GM, et al
    Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study.
    PLoS One. 2014;9:e115553.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: